Gamma glutamyl transferase as an atherogenic predictive marker in acute coronary syndrome

Sujesh Kumar N., Sajitha Krishnan


Background: Acute coronary syndrome (ACS) remains a leading cause of mortality and morbidity world-wide. Atherosclerosis is the predominant cause of ACS and biomarkers that could detect vulnerable atherosclerotic plaque could potentially be of great value in identifying patients at risk of developing coronary events. The aim was to assess the role of gamma-glutamyl transferase (GGT) in atherosclerosis process. The objective was to compare serum levels of GGT in patients with ACS and control subjects, and also to find out the association between GGT and atherogenic risk factors such as diabetes mellitus, hypertension, dyslipidemia and smoking.

Methods: The design was a prospective case control study where a total of 151 patients, 100 ACS patients and 51 control subjects with the age group of 30-80 years were enrolled for the study. GGT was estimated by kinetic colour test using Beckman Coulter AU2700 analyser.

Results: The mean GGT levels of ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina (UA) subgroups were 93.86, 87.87 and 29.27 U/L respectively, which showed statistical significant difference (p<0.001) when compared with control subjects 21.99 U/L. The higher GGT levels in ACS patients also correlated with angiographic diagnosis of atherosclerosis. No significant difference was noted in GGT levels among ACS subgroups having risk factors and without having risk factors. 

Conclusions: Significantly higher GGT levels found in ACS patients reflects the burden of atherosclerotic changes and this association implies that GGT estimation can be used as an adjuvant biomarker that may help in identifying patients who are potentially at risk of coronary atherosclerosis.


Acute coronary syndrome, Atherosclerosis, Gamma-glutamyl transferase, Risk factors

Full Text:





Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Redy KS, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008;371(9622):1435-42.

Sharma M, Ganguly NK. Premature coronary artery diseases in Indians and its associated risk factors. Vasc Health Risk Manag. 2005;1:217-25.


Mackman N. Triggers, targets and treatment for thrombosis. Nature. 2008;451:914-18.

Hajjar DP, Gotto AM Jr. Biological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases. The Am J pathol. 2013;182(5):1474-81.

Whitfield JB. Gamma glutamyl transferase. Critic Reviews Clinic Lab Sci. 2001;38(4):263-355.

Emdin M, Passino C, Pompella A, Paolicchi A. Gamma-glutamyl transferase as a cardiovascular risk factor. Eur Heart J. 2006;27:2145-46.


Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O, Marsik C. Gamma glutamyl transferase and long-term survival: is it just the liver? Clin Chem. 2007;53:940-46.

Mao Y, Qi X, Xu W, Song H, Xu M, Ma W, et al. Serum gamma-glutamyl transferase: a novel biomarker for coronary artery disease. Med Sci Monit. 2014;20:706-10.

Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma glutamyl transferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;112:2130-37.

Wannamethee SG, Ebrahim S, Shaper AG. Gamma-glutamyl transferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol. 1995;142:699-708.


Turgut O, Tandogan I, Gurlek A. Association of gamma-glutamyl transferase with cardiovascular risk: a prognostic outlook. Arch Med Res. 2009;40(4):318-20.

Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, et al. Beta-lipoprotein- and LDL-associated serum gamma-glutamyl transferase in patients with coronary atherosclerosis. Atherosclerosis. 2006;186(1):80-85.

Emdin M, Pompella A, Paolicchi A. Gamma-glutamyl transferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation. 2005;112(14):2078-80.

Emiroglu MY, Esen OB, Bulut M, Karapinar H, Kaya Z, Akcakoyun M, et al. Gamma glutamyl transferase levels and its association with high sensitive C-reactive protein in patients with acute coronary syndromes. N Am J Med Sci. 2010;2:306-10.

Lawton JS. Sex and gender differences in coronary artery disease. Semin Thorac Cardiovasc Surg. 2011;23(2):126-30.

El-Menyar A, Ahmed E, Albinali H, Al-Thani H, Gehani A, Singh R, et al. Mortality trends in women and men presenting with acute coronary syndrome: insights from a 20-year registry. PLoS One. 2013;8(7):e70066.

Noureddine S, Arevian M, Adra M, Puzantian H. Response to signs and symptoms of acute coronary syndrome: differences between Lebanese men and women. Am J Crit Care. 2008;17:26-35.

Sharma M, Ganguly NK. Premature coronary artery disease in Indians and its associated risk factors. Vasc Health Risk Manag. 2005;1(3):217-25.

Shabbir S, Khan DA, Khan FA, Elahi MM, Matata BM. Serum gamma glutamyl transferase: a novel biomarker for screening of premature coronary artery disease. Cardiovas Revascular Medic. 2011;12:367-74.

Pompella A, Emdin M, Passino C, Paolicchi A. The significance of serum gamma glutamyl transferase in cardiovascular diseases. Clin Chem Lab Med. 2004;42:1085-91.

Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, et al. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation. 2004;109:1440.

Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, et al. Gamma-glutamyl transferase activity in human atherosclerotic plaques–biochemical similarities with the circulating enzyme. Atherosclerosis. 2009;202:119-27.

Emdin M, Passino C, Michelassi C, Donato L, Pompella A, Paolicchi A. Additive prognostic value of gamma-glutamyl transferase in coronary artery disease. Int J Cardiol. 2009;136:80-85.

Duran M, Uysal OK, Yilmaz Y, Gunebakmaz O, Arinc H, Topsakal R, et al. Serum gamma-glutamyltransferase and the burden of atherosclerosis in patients with acute coronary syndrome. Turk Kardiyol Dern Ars. 2013;41(4):275-81.

Whitfield JB. Serum gamma-glutamyl transferase and risk of disease. Clin Chem. 2007;53:1-2.

Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27:127-33.

Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma glutamyl transferase is associated with incident vascular events independently of alcohol intake: analysis of the british women’s heart and health study and meta-analysis. Arterioscler Thromb Vasc Biol. 2007;27:2729-35.


Rosengren A, Wallentin L, Simoons M, Gitt AK, Behar S, Battler A, et al. Cardiovascular risk factors and clinical presentation in acute coronary syndromes. Heart. 2005;91(9):1141-47.

Wannamethee SG, Lennon L, Shaper AG. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclero. 2008;201:168-75.

Meisinger C, Doring A, Schneider A, Lowel H. Serum gamma glutamyl transferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclero. 2006;189:297-302.

Onat A, Can G, Ornek E, Cicek G, Ayhan E, Dogan Y. Serum gamma-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease. Obesity. 2012;20:842-48.

Lee DH, Jacobs DR, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyl transferase is a predictor of incident diabetes and hypertension: the Coronary artery risk development in young adults (cardia) study. Clin Chem. 2003;49(8):1358-66.

Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesaniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med. 2000;248:230-8.